Rennova Health Inc (RNVA)

[jmoney360]

INVESTORS BE
AWARE OF NEGATIVE CAMPAIGN

RNVA BULLISH BUY BUY BUY ALERT

No REVERSE SPLIT FACTS

Lagan stated that there were approximately ten billion shares issued and outstanding and that there were two hundred and fifty billion shares authorized meaning that there was no need for a reverse split for the foreseeable future. He confirmed that the Company currently had no plans to complete a reverse split.

To hear Seamus Lagan’s entire interview, follow the link to the podcast here:

https://audioboom.com/posts/8157101-rennova-health-inc-provides-update-to-the-stock-day-podcast.
RNVA present NEWS + more

https://ir.rennovahealth.com/press-releases/detail/335/rennova-health-inc-provides-update-after-filing-2022

https://audioboom.com/posts/8251354-rennova-health-rnva-is-featured-on-the-stock-day-podcast

INVESTORS ALERT BIG IMPROVEMENT

NO FUD

https://www.rennovahealth.com/

https://bigsouthforkmc.com/

From recently filed 10-k

Net revenues were $13.0 million for the year ended December 31, 2022, as compared to $3.2 million for the year ended December 31, 2021, an increase of $9.8 million. We attribute the increase in net revenues primarily due to retroactive and current billings and collections and increased inpatient admissions at our Big South Fork Medical Center. We began billing as a Critical Access Hospital in the three months ended June 30, 2022 retroactive to July 1, 2021.

Direct Costs of Revenues

Direct costs of revenues increased by $1.5 million for the year ended December 31, 2022 compared to 2021. We attribute the increase in 2022 primarily to higher professional fees and salaries and wages, partially offset by lower costs at Jellico due to the lease termination in March 2021. Professional fees increased due to greater inpatient admissions and to the restructuring of our relationships with certain professional service firms. Salaries and wages increased due to greater inpatient admissions, increased non-clinical staffing and reduced contract labor.

Loss from Continuing Operations Before Other Income (Expense) and Income Taxes


Our loss from continuing operations before other income (expense) and income taxes for the year ended December 31, 2022 was $1.4 million compared to a loss of $12.5 million for the year ended December 31, 2021. We attribute the decrease in the operating loss primarily to the increase in net revenues, the asset impairment charge in 2021 as well as the reduction in general and administrative expenses.